Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology
Paige Haas, Monita Muralidharan, Nevan J. Krogan, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 2, pp. 1133-1152
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 224
Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilities
Thomas Kruse, Caroline Benz, Dimitriya H. Garvanska, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 65
Clinical applications of plasma proteomics and peptidomics: Towards precision medicine
Bo He, Zhao Huang, Canhua Huang, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2022) Vol. 16, Iss. 6
Closed Access | Times Cited: 40
Targeted proteomics as a tool to detect SARS-CoV-2 proteins in clinical specimens
Karel Bezstarosti, Mart M. Lamers, Wouter Doff, et al.
PLoS ONE (2021) Vol. 16, Iss. 11, pp. e0259165-e0259165
Open Access | Times Cited: 37
SARS‐CoV‐2 biology and variants: anticipation of viral evolution and what needs to be done
Ruibang Luo, A Delaunay, Kenneth N. Timmis, et al.
Environmental Microbiology (2021) Vol. 23, Iss. 5, pp. 2339-2363
Open Access | Times Cited: 35
Targeted proteomics as a tool to detect SARS-CoV-2 proteins in clinical specimens
Karel Bezstarosti, Mart M. Lamers, Wouter Doff, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 36
DIA-Based Proteome Profiling of Nasopharyngeal Swabs from COVID-19 Patients
Dong‐Gi Mun, Patrick M. Vanderboom, Anil K. Madugundu, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 8, pp. 4165-4175
Open Access | Times Cited: 25
Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches
Merve Çakır, Kirsten Obernier, Antoine Forget, et al.
mSystems (2021) Vol. 6, Iss. 5
Open Access | Times Cited: 25
Discovery Proteomics for COVID-19: Where We Are Now
Angela McArdle, Kirstin E. Washington, Blandine Chazarin Orgel, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 10, pp. 4627-4639
Open Access | Times Cited: 24
Proteomic Analysis of Human Sputum for the Diagnosis of Lung Disorders: Where Are We Today?
Maura D’Amato, Paolo Iadarola, Simona Viglio
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5692-5692
Open Access | Times Cited: 19
Machine Learning-based Host–Pathogen Protein–Protein Interaction Prediction
Erdem Türk, Onur Can Karabulut, Al-shaima Khaled Abdullah Al-alie, et al.
Current Clinical Microbiology Reports (2025) Vol. 12, Iss. 1
Closed Access
Construction and application of SARS-CoV-2 protein ontology (CoVPO)
Aaron Nkhata, Xiaona Shi, Yongjuan Zhang, et al.
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0317589-e0317589
Open Access
Atlas of interactions between SARS-CoV-2 macromolecules and host proteins
Guangnan Li, Zhidong Tang, Weiliang Fan, et al.
Cell Insight (2022) Vol. 2, Iss. 1, pp. 100068-100068
Open Access | Times Cited: 16
Proteomic Analysis of Salivary Extracellular Vesicles from COVID-19 Patients Reveals a Specific Anti-COVID-19 Response Protein Signature
Laura Weber, Alfredo Torres, Ornella Realini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3704-3704
Open Access | Times Cited: 3
Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis
Fernando dos Santos, Joyce B. Li, Nathalia Juocys, et al.
Frontiers in Molecular Biosciences (2023) Vol. 9
Open Access | Times Cited: 7
Amplifying protection against acute lung injury: Targeting both inflammasome and cGAS-STING pathway by Lonicerae Japonicae Flos-Forsythiae Fructus drug pair
Junjie Li, Ming Dong, Qing Yao, et al.
Chinese Herbal Medicines (2024) Vol. 16, Iss. 3, pp. 422-434
Open Access | Times Cited: 2
Circulating Peptidome Is Strongly Altered in COVID-19 Patients
Gianluca Baldanzi, Beatrice Purghè, Beatrice Ragnoli, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 2, pp. 1564-1564
Open Access | Times Cited: 6
MALDI MS-Based Investigations for SARS-CoV-2 Detection
Mariaimmacolata Preianò, Serena Correnti, Corrado Pelaia, et al.
BioChem (2021) Vol. 1, Iss. 3, pp. 250-278
Open Access | Times Cited: 12
Comprehensive proteomic analysis of HCoV-OC43 virions and virus-modulated extracellular vesicles
Negar Joharinia, Éric Bonneil, Nathalie Grandvaux, et al.
Journal of Virology (2024) Vol. 98, Iss. 7
Open Access | Times Cited: 1
Valuable Contributions and Lessons Learned from Proteomics and Metabolomics Studies of COVID-19
Bhaswati Chatterjee, Suman S. Thakur
Journal of Proteome Research (2024) Vol. 23, Iss. 10, pp. 4171-4187
Closed Access | Times Cited: 1
Mass spectrometric approaches in discovering lipid biomarkers for COVID‐19 by lipidomics: Future challenges and perspectives
Siddabasave Gowda B. Gowda, Chandra Shekhar, Divyavani Gowda, et al.
Mass Spectrometry Reviews (2023) Vol. 43, Iss. 5, pp. 1041-1065
Closed Access | Times Cited: 3
Harnessing and bioprospecting botanical-based herbal medicines against potential drug targets for COVID-19: a review coupled molecular docking studies
Tarun Pal, Uttpal Anand, Shreya Sikdar Mitra, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-23
Open Access | Times Cited: 3
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome
Lisa Pagani, Clizia Chinello, Allia Mahajneh, et al.
BioChem (2022) Vol. 2, Iss. 1, pp. 64-82
Open Access | Times Cited: 5
Looking at COVID-19 from a Systems Biology Perspective
Emily Samuela Turilli, Marta Lualdi, Mauro Fasano
Biomolecules (2022) Vol. 12, Iss. 2, pp. 188-188
Open Access | Times Cited: 4
“Multiomics” Approaches to Understand and Treat COVID-19: Mass Spectrometry and Next-Generation Sequencing
Diane Appiasie, Daniel J. Guerra, Kyle Tanguay, et al.
BioChem (2021) Vol. 1, Iss. 3, pp. 210-237
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top